<DOC>
	<DOCNO>NCT00142025</DOCNO>
	<brief_summary>The purpose study determine whether antiepileptic drug oxcarbazepine effective treatment chronic asthma .</brief_summary>
	<brief_title>Study Efficacy Oxcarbazepine Therapy Bronchial Asthma</brief_title>
	<detailed_description>Effective therapy asthma still remain quite serious problem . According GINA definition , asthma inflammatory disorder . Consequently , modern pharmacotherapy asthma provide wide use anti-inflammatory drug . But asthma also paroxysmal disorder : many specialist even guideline underline paroxysmal clinical picture asthma . Besides , accord author , neurogenic inflammation may play important role asthma mechanism . But neurogenic inflammatory paroxysmal disorder exist , migraine trigeminal neuralgia . Some antiepileptic drug , like carbamazepine valproate , effective therapy migraine trigeminal neuralgia - 80 % case . If bronchial asthma also paroxysmal inflammatory disease , like migraine trigeminal neuralgia , possible antiepileptic drug also effective asthma therapy . We perform double-blind , placebo-controlled 3-month trial evaluation oxcarbazepine efficacy therapy bronchial asthma . Oxcarbazepine antiepileptic drug new generation , produce Novartis , effective safe derivative well-known antiepileptic drug carbamazepine . Comparison : Patients receive investigational drug addition usual routine antiasthmatic treatment , compare patient receive placebo addition usual routine antiasthmatic treatment .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Bronchial asthma know least 1 year Absence longterm remission asthma ( last 1 month ) Poorly control asthma , due various reason Nonsmokers Presence concomitant severe diseases Allergy adverse reaction carbamazepine oxcarbazepine Abnormal baseline haematology , blood chemistry urinalysis Current use longacting betaagonists Age young 16 year old Longterm history smoking Pregnancy lactating</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Bronchial asthma</keyword>
	<keyword>Oxcarbazepine</keyword>
	<keyword>Antiepileptic drug</keyword>
	<keyword>Efficacy</keyword>
</DOC>